ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q4SCImago #17,925Hybrid

Memo-Magazine of European Medical Oncology

Acronym:memo
•
Identifier (ISSN):1865-5041(Print)/1865-5076(Online)
•
Publisher:Springer Nature
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.6↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Memo-Magazine of European Medical Oncology

WoS Q4
00110.620230.420240.320250.62026
Annual Impact Factor Metric
Current (2026):0.6
Scopus SJR & RankScopus Q4
0.281
#17,925

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
25

25 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
101articles/year
62.92% Gold OA•39.39% Original Research

Aims & Scope

memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO). The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.

Topics Covered (Recognized by AI)
Medicine94%Internal medicine87.1%Biology86%Genetics75.1%Pathology60.2%Oncology56.6%Cancer51.9%Surgery45.3%Immunology42.6%Chemistry28%Chemotherapy26.6%Biochemistry24.5%Radiology23.6%Psychology23.2%Cancer research23.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ONCOLOGY

Q4
Rank315/333
IndexESCI
JCIESCI2026

ONCOLOGY

Q4
Rank320/333
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.6
Articles / Year34
Total Citations6
2025
IF0.3
Articles / Year75
Total Citations44
2024
IF0.4
Articles / Year68
Total Citations86
2023
IF0.6
Articles / Year87
Total Citations102
2022
IF—
Articles / Year75
Total Citations112

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #17,925Scopus Q4SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q4
0.281

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4
Citations / Doc (2 years)
0.59

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,567 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations105
3-Year Documents209
Citable Documents166

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ4
OncologyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Memo-Magazine of European Medical Oncology (acronym: memo, ISSN: 1865-5041) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Springer Nature in Germany. The periodical holds a Journal Impact Factor (JIF) of 0.60, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.281 (Q4), an H-index of 25.

The journal enforces rigorous peer evaluation with a publication frequency of 4 issues per year, an annual output of approximately 101 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,567 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
4 issues per year
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: bcae5e95-2226-4ada-a5fe-375d525e01ca
Database Updated: 2026-10-01